These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7152546)

  • 1. Once a week radiation treatment in advanced malignancies.
    Hukku S; Vidyasagar MS; Venkatratnam S; Baboo HA; Trivedi J; Patel NL
    Indian J Cancer; 1982; 19(4):214-8. PubMed ID: 7152546
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiation therapy in neoplastic disease.
    Ferree C
    N C Med J; 1979 Jan; 40(1):13-8. PubMed ID: 84342
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiotherapy of tumours by a dynamic dose-fractionation regime combined with oxygen inhalation (preliminary report of 20 cases of tumours localized to the head and neck and uterine cervix).
    Siracká E; Durkovský J; Jancina J; Révész L
    Neoplasma; 1971; 18(6):607-16. PubMed ID: 5160901
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term immune dysfunction after radiotherapy to the head and neck area.
    Verastegui EL; Morales RB; Barrera-Franco JL; Poitevin AC; Hadden J
    Int Immunopharmacol; 2003 Aug; 3(8):1093-1104. PubMed ID: 12860166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of clinical experience in the use of metronidazole as a radiosensitizer of tumors].
    Goldobenko GV; Kherkheulidze ZSh; Shchebetenko IuE; Polotskiĭ BE
    Med Radiol (Mosk); 1983 Jul; 28(7):70-6. PubMed ID: 6348460
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxygen, hyper- and hypobaric. Current and possible future trials.
    Kunkler PB
    Br J Radiol; 1973 Jan; 46(541):73. PubMed ID: 4683335
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
    Adelstein DJ; Saxton JP; Rybicki LA; Esclamado RM; Wood BG; Strome M; Lavertu P; Lorenz RR; Carroll MA
    J Clin Oncol; 2006 Mar; 24(7):1064-71. PubMed ID: 16505425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer.
    Nuyts S; Dirix P; Hermans R; Poorten VV; Delaere P; Weltens C; Van den Bogaert W
    Head Neck; 2007 Aug; 29(8):720-30. PubMed ID: 17315171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of reoxygenation in advanced cancer of the head and neck during the initial course of chemoradiation or radiotherapy alone.
    Dietz A; Vanselow B; Rudat V; Conradt C; Weidauer H; Kallinowski F; Dollner R
    Head Neck; 2003 Jan; 25(1):50-8. PubMed ID: 12478544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoradiation for advanced head and neck cancer: potential for improving results to match those of current treatment modalities for early-stage tumors--long-term results of hyperfractionated chemoradiation with carbogen breathing and anemia correction with erythropoietin.
    Villar A; Martinez JC; de Serdio JL
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1382-8. PubMed ID: 18037586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective studies on mental status and quality of life in patients with head and neck cancer treated by radiation.
    Kohda R; Otsubo T; Kuwakado Y; Tanaka K; Kitahara T; Yoshimura K; Mimura M
    Psychooncology; 2005 Apr; 14(4):331-6. PubMed ID: 15655808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
    BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiotherapy with fast neutrons as palliative treatment of advanced recurrences of previously irradiated head and neck tumors].
    Micke O; Prott FJ; Schäfer U; Willich N
    Rontgenpraxis; 2000; 52(9):287-94. PubMed ID: 10936958
    [No Abstract]   [Full Text] [Related]  

  • 15. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
    Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
    Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results of radiation therapy for locally advanced or recurrent adenoid cystic carcinomas of the head and neck using combined conventional radiation therapy and hypofractionated inverse planned stereotactic radiation therapy.
    Nomoto S; Shioyama Y; Ohga S; Nonoshita T; Ohnishi K; Atsumi K; Terashima K; Nakashima T; Nakamura K; Hirata H; Honda H
    Fukuoka Igaku Zasshi; 2009 Feb; 100(2):59-66. PubMed ID: 19455976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies.
    Mundt AJ; Rotmensch J; Waggoner SE; Yamada D; Langhauser C; Fleming GF
    Gynecol Oncol; 2001 Aug; 82(2):333-7. PubMed ID: 11531289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency.
    Vasanthan A; Mitsumori M; Park JH; Zhi-Fan Z; Yu-Bin Z; Oliynychenko P; Tatsuzaki H; Tanaka Y; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):145-53. PubMed ID: 15629605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
    McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
    Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.